COMPLETED

Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will see if the use of near infrared autofluorescence (NIRAF) detection with a 'Parathyroid Eye (PTeye)' for identifying parathyroid glands (PGs) during total thyroidectomy (TTx) is better than surgeon's detection alone. It compares risk, benefits and outcomes in TTx patients where NIRAF detection with PTeye for parathyroid identification is either used or not used.

Official Title

Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy

Quick Facts

Study Start:2021-12-01
Study Completion:2024-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05022667

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients with thyroid disease who will be undergoing total thyroidectomy (includes patients who have undergone a prior neck exploration for parathyroid disease or other but have an intact thyroid gland).
  2. * Patients with persisting thyroid disease and will be undergoing re-operative or completion thyroidectomy.
  1. * Pregnant women
  2. * Patients with concurrent parathyroid and thyroid disease
  3. * Patients with incidental enlarged parathyroid discovered during thyroidectomy procedure.
  4. * Patients undergoing thyroid lobectomy or partial thyroidectomy

Contacts and Locations

Principal Investigator

Paul Gauger, MD
PRINCIPAL_INVESTIGATOR
University of Michigan

Study Locations (Sites)

The University of Michigan
Ann Arbor, Michigan, 48109
United States

Collaborators and Investigators

Sponsor: University of Michigan

  • Paul Gauger, MD, PRINCIPAL_INVESTIGATOR, University of Michigan

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-12-01
Study Completion Date2024-05-31

Study Record Updates

Study Start Date2021-12-01
Study Completion Date2024-05-31

Terms related to this study

Keywords Provided by Researchers

  • Total Thyroidectomy
  • Intraoperative Parathyroid Identification
  • Near Infrared Autofluorescence
  • Postoperative Hypocalcemia
  • Postoperative Hypoparathyroidism

Additional Relevant MeSH Terms

  • Thyroid Neoplasms
  • Thyroid Diseases
  • Hypoparathyroidism
  • Endocrine System Diseases
  • Endocrine Gland Neoplasms
  • Neoplasms by Site
  • Neoplasms
  • Head and Neck Neoplasms
  • Parathyroid Diseases